MarketInOut Stock Screener Log In | Sign Up

Valiant Laboratories Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 11:03
Valiant Laboratories Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization7,019.89 mln
Float12.62 mln
Earnings Date11/02/2026

EPS

2.81
Stretched

P / E

43.33
High premium

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-2.46
Borderline

Relative Strength

71 / 100
Outperforming

Debt / Equity

0.15
Very low leverage

Business Description

Founded over four decades ago and headquartered in Mumbai, Valiant Laboratories Limited produces paracetamol and specialty chemicals for customers in India and around the world. The company supplies paracetamol across multiple quality standards, making it suitable for relieving common ailments such as headaches, fever, and joint pain. It operates as part of the Dhanvallabh Ventures group.

Key Fundamentals

EPS2.81
P/E43.33
ROE5.57
RPS56.33
ROIC5.22
ROA3.72
Interest Cover8.60
EBITDA, mln358
EV / EBITDA18.87
EV / EBIT24.63
Revenue, mln3,059
EV / Revenue2.21

Quote Details

Last 121.75
Change -2.45 (-1.97%)
Open 121.75
Volume 924
Turnover 112,497
Average Volume 8,345.67

Financial Ratios

Pre-Tax Profit Margin8
Current Ratio1.91
Price / Book2.21
Price / Tangible Book2.21
Debt / Equity0.15
Price / Sales2.22

Financial Strength

Altman Z-Score3.87
Piotroski F-Score 3 / 9
Beneish M-Score-2.46
Price to Graham Number2.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.48% 9 / 100   
1 Month -2.59% 72 / 100   
2 Months 99.17% 99 / 100   
6 Months 81.72% 96 / 100   
1 Year 46.51% 90 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog